APO Research
Talk to an analyst

APO RESEARCH · REPORT

One-Stop Radiotherapy

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global One-Stop Radiotherapy Market Analysis and Forecast 2026-2032

5 June 2026238 pages

Choose your research edition.

Industry ResearchOne-Stop Radiotherapy Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal One-Stop Radiotherapy Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal One-Stop Radiotherapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal One-Stop Radiotherapy Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal One-Stop Radiotherapy Market Analysis and Forecast 2026-2032238 pages · $4,950 USD

Market perspective

The global One-Stop Radiotherapy market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for One-Stop Radiotherapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for One-Stop Radiotherapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for One-Stop Radiotherapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for One-Stop Radiotherapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of One-Stop Radiotherapy include Dunlee, Varian Medical, Siemens Healthcare, Elekta, Ion Beam Applications, GE Healthcare, Shanghai United Imaging Intelligence and Shanghai Datu Medical Technology, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for One-Stop Radiotherapy, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of One-Stop Radiotherapy, also provides the revenue of main regions and countries. Of the upcoming market potential for One-Stop Radiotherapy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the One-Stop Radiotherapy revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global One-Stop Radiotherapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for One-Stop Radiotherapy revenue, projected growth trends, production technology, application and end-user industry.

One-Stop Radiotherapy Segment by Company

Dunlee

Varian Medical

Siemens Healthcare

Elekta

Ion Beam Applications

GE Healthcare

Shanghai United Imaging Intelligence

Shanghai Datu Medical Technology

One-Stop Radiotherapy Segment by Type

Stereotactic Radiosurgery

Stereotactic Body Radiotherapy

Others

One-Stop Radiotherapy Segment by Application

Rectal Cancer

Nasopharyngeal Carcinoma

Bladder Cancer

Lung Cancer

Others

One-Stop Radiotherapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global One-Stop Radiotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of One-Stop Radiotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of One-Stop Radiotherapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of One-Stop Radiotherapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of One-Stop Radiotherapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, One-Stop Radiotherapy revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global One-Stop Radiotherapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Stereotactic Radiosurgery Major Player Table 3. Stereotactic Body Radiotherapy Major Player Table 4. Others Major Player Table 5. Global One-Stop Radiotherapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Rectal Cancer Major Player Table 7. Nasopharyngeal Carcinoma Major Player Table 8. Bladder Cancer Major Player Table 9. Lung Cancer Major Player Table 10. Others Major Player Table 11. One-Stop Radiotherapy Industry Trends Table 12. One-Stop Radiotherapy Industry Drivers Table 13. One-Stop Radiotherapy Industry Opportunities and Challenges Table 14. One-Stop Radiotherapy Industry Restraints Table 15. Global One-Stop Radiotherapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global One-Stop Radiotherapy Market Size by Region (2021-2026) & (US$ Million) Table 17. Global One-Stop Radiotherapy Market Share by Region (2021-2026) Table 18. Global One-Stop Radiotherapy Market Size by Region (2027-2032) & (US$ Million) Table 19. Global One-Stop Radiotherapy Market Share by Region (2027-2032) Table 20. Global One-Stop Radiotherapy Revenue by Players (US$ Million) & (2021-2026) Table 21. Global One-Stop Radiotherapy Revenue Market Share by Players (2021-2026) Table 22. Global One-Stop Radiotherapy Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global One-Stop Radiotherapy Key Players Headquarters & Area Served Table 24. Global One-Stop Radiotherapy Players, Product Type & Application Table 25. Global One-Stop Radiotherapy Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global One-Stop Radiotherapy by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global One-Stop Radiotherapy Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global One-Stop Radiotherapy Revenue by Type (2021-2026) & (US$ Million) Table 30. Global One-Stop Radiotherapy Revenue by Type (2027-2032) & (US$ Million) Table 31. Global One-Stop Radiotherapy Revenue Market Share by Type (2021-2026) Table 32. Global One-Stop Radiotherapy Revenue Market Share by Type (2027-2032) Table 33. Global One-Stop Radiotherapy Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global One-Stop Radiotherapy Revenue by Application (2021-2026) & (US$ Million) Table 35. Global One-Stop Radiotherapy Revenue by Application (2027-2032) & (US$ Million) Table 36. Global One-Stop Radiotherapy Revenue Market Share by Application (2021-2026) Table 37. Global One-Stop Radiotherapy Revenue Market Share by Application (2027-2032) Table 38. Dunlee Company Information Table 39. Dunlee Business Overview Table 40. Dunlee One-Stop Radiotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Dunlee One-Stop Radiotherapy Product Portfolio Table 42. Dunlee Recent Development Table 43. Varian Medical Company Information Table 44. Varian Medical Business Overview Table 45. Varian Medical One-Stop Radiotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Varian Medical One-Stop Radiotherapy Product Portfolio Table 47. Varian Medical Recent Development Table 48. Siemens Healthcare Company Information Table 49. Siemens Healthcare Business Overview Table 50. Siemens Healthcare One-Stop Radiotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Siemens Healthcare One-Stop Radiotherapy Product Portfolio Table 52. Siemens Healthcare Recent Development Table 53. Elekta Company Information Table 54. Elekta Business Overview Table 55. Elekta One-Stop Radiotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Elekta One-Stop Radiotherapy Product Portfolio Table 57. Elekta Recent Development Table 58. Ion Beam Applications Company Information Table 59. Ion Beam Applications Business Overview Table 60. Ion Beam Applications One-Stop Radiotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Ion Beam Applications One-Stop Radiotherapy Product Portfolio Table 62. Ion Beam Applications Recent Development Table 63. GE Healthcare Company Information Table 64. GE Healthcare Business Overview Table 65. GE Healthcare One-Stop Radiotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. GE Healthcare One-Stop Radiotherapy Product Portfolio Table 67. GE Healthcare Recent Development Table 68. Shanghai United Imaging Intelligence Company Information Table 69. Shanghai United Imaging Intelligence Business Overview Table 70. Shanghai United Imaging Intelligence One-Stop Radiotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Shanghai United Imaging Intelligence One-Stop Radiotherapy Product Portfolio Table 72. Shanghai United Imaging Intelligence Recent Development Table 73. Shanghai Datu Medical Technology Company Information Table 74. Shanghai Datu Medical Technology Business Overview Table 75. Shanghai Datu Medical Technology One-Stop Radiotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Shanghai Datu Medical Technology One-Stop Radiotherapy Product Portfolio Table 77. Shanghai Datu Medical Technology Recent Development Table 78. North America One-Stop Radiotherapy Revenue by Type (2021-2026) & (US$ Million) Table 79. North America One-Stop Radiotherapy Revenue by Type (2027-2032) & (US$ Million) Table 80. North America One-Stop Radiotherapy Revenue by Application (2021-2026) & (US$ Million) Table 81. North America One-Stop Radiotherapy Revenue by Application (2027-2032) & (US$ Million) Table 82. North America One-Stop Radiotherapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 83. North America One-Stop Radiotherapy Revenue by Country (2021-2026) & (US$ Million) Table 84. North America One-Stop Radiotherapy Revenue by Country (US$ Million) & (2027-2032) Table 85. Europe One-Stop Radiotherapy Revenue by Type (2021-2026) & (US$ Million) Table 86. Europe One-Stop Radiotherapy Revenue by Type (2027-2032) & (US$ Million) Table 87. Europe One-Stop Radiotherapy Revenue by Application (2021-2026) & (US$ Million) Table 88. Europe One-Stop Radiotherapy Revenue by Application (2027-2032) & (US$ Million) Table 89. Europe One-Stop Radiotherapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. Europe One-Stop Radiotherapy Revenue by Country (2021-2026) & (US$ Million) Table 91. Europe One-Stop Radiotherapy Revenue by Country (US$ Million) & (2027-2032) Table 92. China One-Stop Radiotherapy Revenue by Type (2021-2026) & (US$ Million) Table 93. China One-Stop Radiotherapy Revenue by Type (2027-2032) & (US$ Million) Table 94. China One-Stop Radiotherapy Revenue by Application (2021-2026) & (US$ Million) Table 95. China One-Stop Radiotherapy Revenue by Application (2027-2032) & (US$ Million) Table 96. Asia One-Stop Radiotherapy Revenue by Type (2021-2026) & (US$ Million) Table 97. Asia One-Stop Radiotherapy Revenue by Type (2027-2032) & (US$ Million) Table 98. Asia One-Stop Radiotherapy Revenue by Application (2021-2026) & (US$ Million) Table 99. Asia One-Stop Radiotherapy Revenue by Application (2027-2032) & (US$ Million) Table 100. Asia One-Stop Radiotherapy Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Asia One-Stop Radiotherapy Revenue by Region (US$ Million) & (2021-2026) Table 102. Asia One-Stop Radiotherapy Revenue by Region (US$ Million) & (2027-2032) Table 103. SAMEA One-Stop Radiotherapy Revenue by Type (2021-2026) & (US$ Million) Table 104. SAMEA One-Stop Radiotherapy Revenue by Type (2027-2032) & (US$ Million) Table 105. SAMEA One-Stop Radiotherapy Revenue by Application (2021-2026) & (US$ Million) Table 106. SAMEA One-Stop Radiotherapy Revenue by Application (2027-2032) & (US$ Million) Table 107. SAMEA One-Stop Radiotherapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. SAMEA One-Stop Radiotherapy Revenue by Country (2021-2026) & (US$ Million) Table 109. SAMEA One-Stop Radiotherapy Revenue by Country (US$ Million) & (2027-2032) Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. One-Stop Radiotherapy Image Figure 2. Global One-Stop Radiotherapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global One-Stop Radiotherapy Market Size Share 2021 VS 2025 VS 2032 Figure 4. Stereotactic Radiosurgery Image Figure 5. Stereotactic Body Radiotherapy Image Figure 6. Others Image Figure 7. Global One-Stop Radiotherapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global One-Stop Radiotherapy Market Size Share 2021 VS 2025 VS 2032 Figure 9. Rectal Cancer Image Figure 10. Nasopharyngeal Carcinoma Image Figure 11. Bladder Cancer Image Figure 12. Lung Cancer Image Figure 13. Others Image Figure 14. Global One-Stop Radiotherapy Market Size (US$ Million) & (2021-2032) Figure 15. Global One-Stop Radiotherapy Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global One-Stop Radiotherapy Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global One-Stop Radiotherapy Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global One-Stop Radiotherapy Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global One-Stop Radiotherapy Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global One-Stop Radiotherapy Revenue Market Share by Type (2021-2032) Figure 22. Global One-Stop Radiotherapy Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global One-Stop Radiotherapy Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global One-Stop Radiotherapy Revenue Market Share by Application (2021-2032) Figure 25. North America One-Stop Radiotherapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America One-Stop Radiotherapy Revenue Share by Type (2021-2032) Figure 27. North America One-Stop Radiotherapy Revenue Share by Application (2021-2032) Figure 28. North America One-Stop Radiotherapy Revenue Share by Country (2021-2032) Figure 29. United States One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe One-Stop Radiotherapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe One-Stop Radiotherapy Revenue Share by Type (2021-2032) Figure 34. Europe One-Stop Radiotherapy Revenue Share by Application (2021-2032) Figure 35. Europe One-Stop Radiotherapy Revenue Share by Country (2021-2032) Figure 36. Germany One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China One-Stop Radiotherapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China One-Stop Radiotherapy Revenue Share by Type (2021-2032) Figure 46. China One-Stop Radiotherapy Revenue Share by Application (2021-2032) Figure 47. Asia One-Stop Radiotherapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia One-Stop Radiotherapy Revenue Share by Type (2021-2032) Figure 49. Asia One-Stop Radiotherapy Revenue Share by Application (2021-2032) Figure 50. Asia One-Stop Radiotherapy Revenue Share by Region (2021-2032) Figure 51. Japan One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA One-Stop Radiotherapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA One-Stop Radiotherapy Revenue Share by Type (2021-2032) Figure 59. SAMEA One-Stop Radiotherapy Revenue Share by Application (2021-2032) Figure 60. SAMEA One-Stop Radiotherapy Revenue Share by Country (2021-2032) Figure 61. Brazil One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt One-Stop Radiotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Stereotactic Radiosurgery
  • Stereotactic Body Radiotherapy
  • Others
Applications
  • Rectal Cancer
  • Nasopharyngeal Carcinoma
  • Bladder Cancer
  • Lung Cancer
  • Others
Companies covered
  • Dunlee
  • Varian Medical
  • Siemens Healthcare
  • Elekta
  • Ion Beam Applications
  • GE Healthcare
  • Shanghai United Imaging Intelligence
  • Shanghai Datu Medical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 One-Stop Radiotherapy Market by Type
  3. 1.2.1 Global One-Stop Radiotherapy Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Stereotactic Radiosurgery
  5. 1.2.3 Stereotactic Body Radiotherapy
  6. 1.2.4 Others
  7. 1.3 One-Stop Radiotherapy Market by Application
  8. 1.3.1 Global One-Stop Radiotherapy Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Rectal Cancer
  10. 1.3.3 Nasopharyngeal Carcinoma
  11. 1.3.4 Bladder Cancer
  12. 1.3.5 Lung Cancer
  13. 1.3.6 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 One-Stop Radiotherapy Market Dynamics
  1. 2.1 One-Stop Radiotherapy Industry Trends
  2. 2.2 One-Stop Radiotherapy Industry Drivers
  3. 2.3 One-Stop Radiotherapy Industry Opportunities and Challenges
  4. 2.4 One-Stop Radiotherapy Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global One-Stop Radiotherapy Market Perspective (2021-2032)
  2. 3.2 Global One-Stop Radiotherapy Growth Trends by Region
  3. 3.2.1 Global One-Stop Radiotherapy Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global One-Stop Radiotherapy Market Size by Region (2021-2026)
  5. 3.2.3 Global One-Stop Radiotherapy Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global One-Stop Radiotherapy Revenue by Players
  2. 4.1.1 Global One-Stop Radiotherapy Revenue by Players (2021-2026)
  3. 4.1.2 Global One-Stop Radiotherapy Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global One-Stop Radiotherapy Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global One-Stop Radiotherapy Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global One-Stop Radiotherapy Key Players Headquarters & Area Served
  7. 4.4 Global One-Stop Radiotherapy Players, Product Type & Application
  8. 4.5 Global One-Stop Radiotherapy Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global One-Stop Radiotherapy Market CR5 and HHI
  11. 4.6.3 2025 One-Stop Radiotherapy Tier 1, Tier 2, and Tier 3
5 One-Stop Radiotherapy Market Size by Type
  1. 5.1 Global One-Stop Radiotherapy Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global One-Stop Radiotherapy Revenue by Type (2021-2032)
  3. 5.3 Global One-Stop Radiotherapy Revenue Market Share by Type (2021-2032)
6 One-Stop Radiotherapy Market Size by Application
  1. 6.1 Global One-Stop Radiotherapy Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global One-Stop Radiotherapy Revenue by Application (2021-2032)
  3. 6.3 Global One-Stop Radiotherapy Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Dunlee
  2. 7.1.1 Dunlee Company Information
  3. 7.1.2 Dunlee Business Overview
  4. 7.1.3 Dunlee One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Dunlee One-Stop Radiotherapy Product Portfolio
  6. 7.1.5 Dunlee Recent Developments
  7. 7.2 Varian Medical
  8. 7.2.1 Varian Medical Company Information
  9. 7.2.2 Varian Medical Business Overview
  10. 7.2.3 Varian Medical One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Varian Medical One-Stop Radiotherapy Product Portfolio
  12. 7.2.5 Varian Medical Recent Developments
  13. 7.3 Siemens Healthcare
  14. 7.3.1 Siemens Healthcare Company Information
  15. 7.3.2 Siemens Healthcare Business Overview
  16. 7.3.3 Siemens Healthcare One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Siemens Healthcare One-Stop Radiotherapy Product Portfolio
  18. 7.3.5 Siemens Healthcare Recent Developments
  19. 7.4 Elekta
  20. 7.4.1 Elekta Company Information
  21. 7.4.2 Elekta Business Overview
  22. 7.4.3 Elekta One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Elekta One-Stop Radiotherapy Product Portfolio
  24. 7.4.5 Elekta Recent Developments
  25. 7.5 Ion Beam Applications
  26. 7.5.1 Ion Beam Applications Company Information
  27. 7.5.2 Ion Beam Applications Business Overview
  28. 7.5.3 Ion Beam Applications One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Ion Beam Applications One-Stop Radiotherapy Product Portfolio
  30. 7.5.5 Ion Beam Applications Recent Developments
  31. 7.6 GE Healthcare
  32. 7.6.1 GE Healthcare Company Information
  33. 7.6.2 GE Healthcare Business Overview
  34. 7.6.3 GE Healthcare One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
  35. 7.6.4 GE Healthcare One-Stop Radiotherapy Product Portfolio
  36. 7.6.5 GE Healthcare Recent Developments
  37. 7.7 Shanghai United Imaging Intelligence
  38. 7.7.1 Shanghai United Imaging Intelligence Company Information
  39. 7.7.2 Shanghai United Imaging Intelligence Business Overview
  40. 7.7.3 Shanghai United Imaging Intelligence One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Shanghai United Imaging Intelligence One-Stop Radiotherapy Product Portfolio
  42. 7.7.5 Shanghai United Imaging Intelligence Recent Developments
  43. 7.8 Shanghai Datu Medical Technology
  44. 7.8.1 Shanghai Datu Medical Technology Company Information
  45. 7.8.2 Shanghai Datu Medical Technology Business Overview
  46. 7.8.3 Shanghai Datu Medical Technology One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Shanghai Datu Medical Technology One-Stop Radiotherapy Product Portfolio
  48. 7.8.5 Shanghai Datu Medical Technology Recent Developments
8 North America
  1. 8.1 North America One-Stop Radiotherapy Revenue (2021-2032)
  2. 8.2 North America One-Stop Radiotherapy Revenue by Type (2021-2032)
  3. 8.2.1 North America One-Stop Radiotherapy Revenue by Type (2021-2026)
  4. 8.2.2 North America One-Stop Radiotherapy Revenue by Type (2027-2032)
  5. 8.3 North America One-Stop Radiotherapy Revenue Share by Type (2021-2032)
  6. 8.4 North America One-Stop Radiotherapy Revenue by Application (2021-2032)
  7. 8.4.1 North America One-Stop Radiotherapy Revenue by Application (2021-2026)
  8. 8.4.2 North America One-Stop Radiotherapy Revenue by Application (2027-2032)
  9. 8.5 North America One-Stop Radiotherapy Revenue Share by Application (2021-2032)
  10. 8.6 North America One-Stop Radiotherapy Revenue by Country
  11. 8.6.1 North America One-Stop Radiotherapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America One-Stop Radiotherapy Revenue by Country (2021-2026)
  13. 8.6.3 North America One-Stop Radiotherapy Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe One-Stop Radiotherapy Revenue (2021-2032)
  2. 9.2 Europe One-Stop Radiotherapy Revenue by Type (2021-2032)
  3. 9.2.1 Europe One-Stop Radiotherapy Revenue by Type (2021-2026)
  4. 9.2.2 Europe One-Stop Radiotherapy Revenue by Type (2027-2032)
  5. 9.3 Europe One-Stop Radiotherapy Revenue Share by Type (2021-2032)
  6. 9.4 Europe One-Stop Radiotherapy Revenue by Application (2021-2032)
  7. 9.4.1 Europe One-Stop Radiotherapy Revenue by Application (2021-2026)
  8. 9.4.2 Europe One-Stop Radiotherapy Revenue by Application (2027-2032)
  9. 9.5 Europe One-Stop Radiotherapy Revenue Share by Application (2021-2032)
  10. 9.6 Europe One-Stop Radiotherapy Revenue by Country
  11. 9.6.1 Europe One-Stop Radiotherapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe One-Stop Radiotherapy Revenue by Country (2021-2026)
  13. 9.6.3 Europe One-Stop Radiotherapy Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China One-Stop Radiotherapy Revenue (2021-2032)
  2. 10.2 China One-Stop Radiotherapy Revenue by Type (2021-2032)
  3. 10.2.1 China One-Stop Radiotherapy Revenue by Type (2021-2026)
  4. 10.2.2 China One-Stop Radiotherapy Revenue by Type (2027-2032)
  5. 10.3 China One-Stop Radiotherapy Revenue Share by Type (2021-2032)
  6. 10.4 China One-Stop Radiotherapy Revenue by Application (2021-2032)
  7. 10.4.1 China One-Stop Radiotherapy Revenue by Application (2021-2026)
  8. 10.4.2 China One-Stop Radiotherapy Revenue by Application (2027-2032)
  9. 10.5 China One-Stop Radiotherapy Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia One-Stop Radiotherapy Revenue (2021-2032)
  2. 11.2 Asia One-Stop Radiotherapy Revenue by Type (2021-2032)
  3. 11.2.1 Asia One-Stop Radiotherapy Revenue by Type (2021-2026)
  4. 11.2.2 Asia One-Stop Radiotherapy Revenue by Type (2027-2032)
  5. 11.3 Asia One-Stop Radiotherapy Revenue Share by Type (2021-2032)
  6. 11.4 Asia One-Stop Radiotherapy Revenue by Application (2021-2032)
  7. 11.4.1 Asia One-Stop Radiotherapy Revenue by Application (2021-2026)
  8. 11.4.2 Asia One-Stop Radiotherapy Revenue by Application (2027-2032)
  9. 11.5 Asia One-Stop Radiotherapy Revenue Share by Application (2021-2032)
  10. 11.6 Asia One-Stop Radiotherapy Revenue by Country
  11. 11.6.1 Asia One-Stop Radiotherapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia One-Stop Radiotherapy Revenue by Country (2021-2026)
  13. 11.6.3 Asia One-Stop Radiotherapy Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA One-Stop Radiotherapy Revenue (2021-2032)
  2. 12.2 SAMEA One-Stop Radiotherapy Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA One-Stop Radiotherapy Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA One-Stop Radiotherapy Revenue by Type (2027-2032)
  5. 12.3 SAMEA One-Stop Radiotherapy Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA One-Stop Radiotherapy Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA One-Stop Radiotherapy Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA One-Stop Radiotherapy Revenue by Application (2027-2032)
  9. 12.5 SAMEA One-Stop Radiotherapy Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA One-Stop Radiotherapy Revenue by Country
  11. 12.6.1 SAMEA One-Stop Radiotherapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA One-Stop Radiotherapy Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA One-Stop Radiotherapy Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst